Literature DB >> 18388159

Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis.

S Ishikawa1, T Mima, C Aoki, N Yoshio-Hoshino, Y Adachi, T Imagawa, M Mori, M Tomiita, N Iwata, T Murata, M Miyoshi, S Takei, Y Aihara, S Yokota, K Matsubara, N Nishimoto.   

Abstract

OBJECTIVES: Systemic juvenile idiopathic arthritis (sJIA) is a rheumatic disease in childhood characterised by systemic symptoms and a relatively poor prognosis. Peripheral leukocytes are thought to play a pathological role in sJIA although the exact cause of the disease is still obscure. In this study, we aimed to clarify cellular functional abnormalities in sJIA.
METHODS: We analysed the gene expression profile in peripheral leukocytes from 51 patients with sJIA, 6 patients with polyarticular type JIA (polyJIA) and 8 healthy children utilising DNA microarrays. Gene ontology analysis and network analysis were performed on the genes differentially expressed in sJIA to clarify the cellular functional abnormalities. RESULT: A total of 3491 genes were differentially expressed in patients with sJIA compared to healthy individuals. They were functionally categorised mainly into a defence response group and a metabolism group according to gene ontology, suggesting the possible abnormalities in these functions. In the defence response group, molecules predominantly constituting interferon (IFN)gamma and tumour necrosis factor (TNF) network cascades were upregulated. In the metabolism group, oxidative phosphorylation-related genes were downregulated, suggesting a mitochondrial disorder. Expression of mitochondrial DNA-encoded genes including cytochrome c oxidase subunit 1(MT-CO1) and MT-CO2 were suppressed in patients with sJIA but not in patients with polyJIA or healthy children. However, nuclear DNA-encoded cytochrome c oxidases were intact.
CONCLUSION: Our findings suggest that sJIA is not only an immunological disease but also a metabolic disease involving mitochondria disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388159     DOI: 10.1136/ard.2007.079533

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

Review 1.  Access to immunology through the Gene Ontology.

Authors:  Ruth C Lovering; Evelyn B Camon; Judith A Blake; Alexander D Diehl
Journal:  Immunology       Date:  2008-10       Impact factor: 7.397

Review 2.  Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).

Authors:  Emely L Verweyen; Grant S Schulert
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

3.  Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Authors:  Xuefeng B Ling; Kenneth Lau; Chetan Deshpande; Jane L Park; Diana Milojevic; Claudia Macaubas; Chris Xiao; Viorica Lopez-Avila; John Kanegaye; Jane C Burns; Harvey Cohen; James Schilling; Elizabeth D Mellins
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

4.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

5.  Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus.

Authors:  Hooi-Ming Lee; Hidehiko Sugino; Chieko Aoki; Norihiro Nishimoto
Journal:  Arthritis Res Ther       Date:  2011-04-15       Impact factor: 5.156

6.  Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis.

Authors:  Hooi-Ming Lee; Hidehiko Sugino; Chieko Aoki; Yasunori Shimaoka; Ryuji Suzuki; Kensuke Ochi; Takahiro Ochi; Norihiro Nishimoto
Journal:  Arthritis Res Ther       Date:  2011-06-16       Impact factor: 5.156

7.  Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone.

Authors:  Carl K Edwards; Julie S Green; Hans-Dieter Volk; Michael Schiff; Brian L Kotzin; Hiroaki Mitsuya; Tatsuya Kawaguchi; Ken-Mei Sakata; John Cheronis; David Trollinger; Danute Bankaitis-Davis; Charles A Dinarello; David A Norris; Michael P Bevilacqua; Mayumi Fujita; Gerd-Rudiger Burmester
Journal:  Front Immunol       Date:  2012-12-04       Impact factor: 7.561

8.  Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.

Authors:  Xuefeng B Ling; Claudia Macaubas; Heather C Alexander; Qiaojun Wen; Edward Chen; Sihua Peng; Yue Sun; Chetan Deshpande; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Sheng-Yung P Chang; Tzielan Lee; Christy Sandborg; Ann B Begovich; Stanley N Cohen; Elizabeth D Mellins
Journal:  BMC Med       Date:  2012-10-23       Impact factor: 8.775

9.  Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus.

Authors:  Hooi-Ming Lee; Toru Mima; Hidehiko Sugino; Chieko Aoki; Yasuo Adachi; Naoko Yoshio-Hoshino; Kenichi Matsubara; Norihiro Nishimoto
Journal:  Arthritis Res Ther       Date:  2009-01-03       Impact factor: 5.156

10.  Functional annotation of rheumatoid arthritis and osteoarthritis associated genes by integrative genome-wide gene expression profiling analysis.

Authors:  Zhan-Chun Li; Jie Xiao; Jin-Liang Peng; Jian-Wei Chen; Tao Ma; Guang-Qi Cheng; Yu-Qi Dong; Wei-Li Wang; Zu-De Liu
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.